Abstract 1039: Individualized tumor-informed circulating tumor DNA (ctDNA) analysis for postoperative monitoring of non-small cell lung cancer (NSCLC) - the MEDAL study

医学 肺癌 内科学 微小残留病 肿瘤科 循环肿瘤DNA 阶段(地层学) 癌症 胃肠病学 白血病 生物 古生物学
作者
Kezhong Chen,Chenyang Wang,Haifeng Shen,Xi Li,Yichen Jin,Shuailai Wu,Fujun Qiu,Qiang Lü,Di Peng,Shuai Fang,Bing Li,Juan Lv,Jinlei Song,Yang Wang,Shannon Chuai,Zhihong Zhang
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:83 (7_Supplement): 1039-1039
标识
DOI:10.1158/1538-7445.am2023-1039
摘要

Abstract Background: Through parallel testing and comparison of personalized and fixed panel minimal residual disease (MRD) assays, to establish the best technique and application strategy of dynamic MRD detection for prognosis prediction and disease assessment among non-small cell lung cancer (NSCLC) patients. Method: We analyzed 760 plasma samples from prospectively enrolled 181 patients with NSCLC recruited to the MEDAL study (NCT03634826), with disease stage I (63%), II (19%) and III (18%). 80% were adenocarcinomas. Plasma samples were collected at baseline (n=157), landmark 3-day and 1-month (n=334), and longitudinal points (n=248) were analyzed. Additional plasma was collected after relapse for 14 patients (n=21). Median follow-up was 1092 days, and 48 patients progressed. We employed a novel personalized tumor-informed technology named PROPHET using deep sequencing of 50 patient-specific variants. The PROPHET was developed to detect MRD with a limit of detection (LoD) of 0.004% and sample-level specificity of greater than 99% in the analytical validation. Detection and quantification of MRD through tumor-informed (TI) and tumor-agnostic (TA) fixed panel assays in the same samples were conducted for a head-to-head comparison. Results: ctDNA was detected by PROPHET prior to treatment in 45% of samples (83%, 75% and 23% for disease stage III, II and I), and showed a higher positive rate than the TI and TA assays (22% and 19%). PROPHET identified 30 more ctDNA positive patients with a median ctDNA fraction of 0.01% at baseline. From the landmark single test, the sensitivity was 45%; integrating longitudinal time points increased the sensitivity to 85%. Landmark PROPHET status was the only risk factor other than clinical features to predict the clinical relapse (p<0.001, multivariate Cox model). MRD positive patients defined by non-canonical variants (n=8) had similar disease-free survival (DFS) as MRD positive patients defined by canonical variants (n=9). Landmark PROPHET-based MRD status combined with clinical TNM stage outperformed TNM stage for prediction of prognosis (p<0.001). Longitudinal MRD achieved negative predictive value (NPV) of 99% with an interval of 150 days, and demonstrated 299 days of longer lead-time than other state-of-the-art fixed-panel assays. Among 16 patients with equivocal radiological diagnosis, all the MRD positive patients relapsed (n=6). Among relapsed patients received next-line treatments, 7 ctDNA negative patients survived or died other disease, 67% (2/3) ctDNA positive patients died from cancer. Sensitivity for bone and brain metastasis was 100% (11/11) and 50% (2/4), respectively. Conclusion: The sensitive tumor-informed personalized MRD approach could provide advantages in prognosis prediction at landmark and disease assessment during surveillance for NSCLC patients. Citation Format: Kezhong Chen, Chenyang Wang, Haifeng Shen, Xi Li, Yichen Jin, Shuailai Wu, Fujun Qiu, Qiang Lu, Di Peng, Shuai Fang, Bing Li, Juan Lv, Jinlei Song, Yang Wang, Shannon Chuai, Zhihong Zhang. Individualized tumor-informed circulating tumor DNA (ctDNA) analysis for postoperative monitoring of non-small cell lung cancer (NSCLC) - the MEDAL study [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 1039.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
扶苏完成签到,获得积分10
1秒前
1秒前
完美世界的应助被顾北采纳,获得10
1秒前
PJT-8450完成签到,获得积分10
1秒前
wang完成签到,获得积分10
2秒前
zhang完成签到 ,获得积分10
2秒前
万能图书馆的应助被dakjdia采纳,获得10
2秒前
嘻嘻哈哈的应助被Hoshino采纳,获得10
2秒前
弱智少年QAQ完成签到,获得积分10
2秒前
顾矜的应助被丁驰采纳,获得10
2秒前
独特忆山完成签到,获得积分10
2秒前
2秒前
独特的靖琪完成签到,获得积分20
3秒前
开朗熊猫发布了新的文献求助10
3秒前
3秒前
3秒前
boiqn完成签到,获得积分10
4秒前
4秒前
顺利的程完成签到 ,获得积分10
4秒前
4秒前
郑希泽发布了新的文献求助10
5秒前
selinann完成签到,获得积分10
5秒前
5秒前
6秒前
小鱼干完成签到,获得积分10
6秒前
柠檬酸不酸完成签到,获得积分10
6秒前
vivi发布了新的文献求助10
6秒前
koala发布了新的文献求助10
7秒前
虚心的大门完成签到,获得积分10
7秒前
7秒前
王小圈完成签到 ,获得积分10
7秒前
慕青的应助被yxy采纳,获得10
7秒前
7秒前
7秒前
7秒前
yinhao发布了新的文献求助20
7秒前
沉沉叠叠发布了新的文献求助10
7秒前
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Markov Decision Processes and Reinforcement Learning 700
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8170021
求助须知:如何正确求助?哪些是违规求助? 9563040
关于积分的说明 21768210
捐赠科研通 7761506
什么是DOI,文献DOI怎么找? 3430553
关于科研通互助平台的介绍 2554373
邀请新用户注册赠送积分活动 2475269